Key points are not available for this paper at this time.
ADVERTISEMENT RETURN TO ISSUEPerspectiveNEXTRecent Developments in Fragment-Based Drug DiscoveryMiles Congreve*, Gianni Chessari, Dominic Tisi, and Andrew J. WoodheadView Author Information Astex Therapeutics Ltd., 436 Cambridge Science Park, Milton Road, Cambridge CB4 0QA, U.K.* To whom correspondence should be addressed. Phone: +44 (0)1223 226270. Fax +44 (0)1223 226201. E-mail: email protectedCite this: J. Med. Chem. 2008, 51, 13, 3661–3680Publication Date (Web):May 6, 2008Publication History Received15 January 2008Published online6 May 2008Published inissue 1 July 2008https://pubs.acs.org/doi/10.1021/jm8000373https://doi.org/10.1021/jm8000373review-articleACS PublicationsCopyright © 2008 American Chemical SocietyRequest reuse permissionsArticle Views17109Altmetric-Citations527LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Drug discovery,Inhibitors,Molecules,Optimization,Screening assays Get e-Alerts
Congreve et al. (2008) studied this question.